Skip to content
Wealthy Investor Report

Wealthy Investor Report

  • Home
  • Domestic
  • Business
  • Money
  • Top News
  • Newsletters

Ozempic is displayed in a pharmacy in Provo

A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo

Post navigation

Eli Lilly is still seeking UK approval on pen for weight-loss drug

Recent Posts

  • Are Business Services Stocks Lagging ADEIA INC (ADEA) This Year?
  • 3 High-Yield Energy Stocks to Buy in February
  • Why Investors Need to Take Advantage of These 2 Consumer Discretionary Stocks Now
  • Software stocks struggle, Google’s AI spending, layoffs surge and more in Morning Squawk
  • 3 Wireless Non-US Stocks Likely to Sail Through Buoyant Industry

Categories

  • Business
  • Domestic
  • Economy
  • Latest News
  • Money
  • Newsletters
  • Politics
  • Top News
  • Uncategorized
  • Privacy Policy of GBM Media Group, LLC
  • Terms of Service/Use Agreement
  • Disclaimer
  • Contact Us

Copyright © 2026 Wealthy Investor Report | Visionary News by Ascendoor | Powered by WordPress.